Skip to content

Telethon Kids is seeking partners to develop and commercialise our technology opportunities. We are looking for investment, collaboration and licensing partners for our technologies. Below are the list of opportunities available for partnering. Please contact us at commercialisation@telethonkids.org.au if you wish to discuss any of these opportunities, or any other areas of commercial interest.

Therapeutic
Technology name Disease Modality Mechanism of Action Development stage Partnering available
Immunotherapy Gel Oncology Solid Tumors dsRNA TLR 3 agonist Pre-clinical Yes
Epithelial Cell Repair Asthma IBD IPF Small molecule Undisclosed Hit discovery Yes
SpritzOM Otitis Media Live biotherapeutic Undisclosed Pre-clinical Yes
Taste Masking Product Pain/anxiety relief Small molecule reformulation NA Regulatory Yes
Bacteriophage Therapy AMR Live biotherapeutic Phage Pre-clinical Yes
Diagnositc Tools
Technology name Disease Technology Development stage Partnering available
VUS Diagnosis Pipeline for Rare Genetic Disease Genetic disease gene mutation Next Generation Sequencing In development Yes
PoC Antibiotic Resistance Test Strep A Isothermal DNA Amplification In development Yes
Social and behavioural sciences
Technology name Description
QI-disability QI-disability was developed to specifically assess the quality of life of children and adolescents with intellectual disability. It is available for licensing as an outcome measure for clinical trials. Find out more.
Friendly Schools Friendly Schools helps build critical social and emotional skills, create positive, safe and supportive learning environments, and significantly reduce bullying in both primary and secondary schools. Find out more.
CUES Autism Group Therapy

Group therapy for parents or other primary caregivers that helps families understand how to support and mange their child’s challenges with uncertainty in everyday environments.

Inklings

Inklings is a program for babies aged 6-18 months who are showing early differences in their social interaction and communication development. Find out more.

Digital health and software solutions
Technology name Description Development stage Partnering available
Virtual WA Modelling software that uses big data to map out physical and social geography. Preliminary validation Yes
AI Platform for Articulating Methods and Reason Software that accurately, equitably, and automatically interprets highly complex and multi-dimensional data. Proof of feasibility Yes
Act1ve app Diabetes type 1 App that contains exercise guidelines and tailored advice specifically for young people living with T1D.

Prototype

Yes

Alex Hart

Alex Hart

Acting Head, Innovation
alex.hart@telethonkids.org.au
0401 190 202

Renaud Quantin

Dr Renaud Quantin

Commercialisation Manager
renaud.quantin@telethonkids.org.au
0413 847 834

David Menegola

David Menegola

Commercialisation Officer
david.menegola@telethonkids.org.au
0448 832 970

Ashley Schoof

Ashley Schoof

Commercialisation Officer
ashley.schoof@telethonkids.org.au
0432 848 547

Discover. Prevent. Cure.

About Telethon Kids Institute

Telethon Kids Institute is one of the largest and most successful medical research institutes in Australia. We've created a bold blueprint that brings together community, researchers, practitioners, policy makers and funders, who share our vision to improve the health and wellbeing of children through excellence in research.

The Institute is headed by leading paediatrician and infectious diseases expert Professor Jonathan Carapetis, with Founding Director Professor Fiona Stanley now Patron.

Telethon Kids is independent and not-for-profit. The majority of funding comes from our success in winning national and international competitive research grants.  We also receive significant philanthropic support from corporate Australia and the community.